Influence of abiraterone and enzalutamide on body composition in patients with metastatic castration resistant prostate cancer

Influence of abiraterone and enzalutamide on body composition in patients with metastatic castration resistant prostate cancer

Structured abstract: Introduction: Loss of skeletal muscle (SM) and gain of subcutaneous fat (SCF) are known side-effects of androgen-deprivation in treatment of prostate cancer. Scarce data is available concerning the effects of abiraterone/pred (ABI) on body composition and no published data rega...

Full description

Bibliographic Details
Main Authors: Stefanie Fischer, Sebastian Clements, Alan McWilliam, Andrew Green, Tine Descamps, Christoph Oing, Silke Gillessen
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Abiraterone
Enzalutamide
Muscle loss
Prostate cancer
Sarcopenia
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294220300915

Internet

http://www.sciencedirect.com/science/article/pii/S2468294220300915

Similar Items